GDOC GOLDMAN SACHS FUTURE HEALTH CARE EQUITY ETF
- 33.387
- -0.019-0.06%
Boston Scientific Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Boston Scientific (BSX) and CureVac (CVAC)
Citigroup Raises Boston Scientific's Price Target to $85 From $79
Analysts Have Conflicting Sentiments on These Healthcare Companies: Humana (HUM), Boston Scientific (BSX) and Biogen (BIIB)
Leerink Partners Adjusts Danaher Price Target to $275 From $265
Analysts Offer Insights on Healthcare Companies: Biogen (BIIB) and BioMarin Pharmaceutical (BMRN)
RBC Raises Price Target on Danaher to $297 From $284, Keeps Outperform Rating
Danaher Analyst Ratings
Goldman Sachs Raises Danaher Price Target to $220 From $215
Evercore ISI Adjusts Price Target on Danaher to $266 From $260
Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS), Telix Pharmaceuticals Ltd. (OtherTLPPF) and Intuitive Surgical (ISRG)
BioMarin Pharmaceutical (BMRN) Receives a Buy From Piper Sandler
Intuitive Surgical (ISRG) Gets a Buy From Barclays
Analysts Conflicted on These Healthcare Names: SAGE Therapeutics (SAGE), Accolade (ACCD) and Intuitive Surgical (ISRG)
Intuitive Surgical Analyst Ratings
Intuitive Surgical (ISRG) Receives a Hold From Oppenheimer
Piper Sandler Keeps Their Buy Rating on Intuitive Surgical (ISRG)
Analysts Are Bullish on Top Healthcare Stocks: Intuitive Surgical (ISRG), Revolution Medicines (RVMD)
Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV), Sarepta Therapeutics (SRPT) and Intuitive Surgical (ISRG)
Intuitive Surgical Analyst Ratings